Category

Investor and VC News

The Effect Of Brexit On Venture Investing

By | Brand, Current Affairs, Entrepreneurs, Investor and VC News, Knowledge, Partner Insight

The Brexit Referendum has come and gone but has left a legacy of conversation and debate in the UK and around the world. From education and trade issues to tourism and technology, Brexit has been talked about a great deal (probably too much!) over the last two weeks. As a law firm at the heart of the UK’s thriving technology and life science sectors, we have experienced firsthand the concerns of entrepreneurs and investors alike. We wanted to candidly share our views on what we’re seeing as effects of Brexit vote – and what we therefore might expect to see – in…

Read More

Launches And Exits: Magic Pony, BleepBleeps and So-Sure

By | Client news, Entrepreneurs, Investor and VC News, Startups | No Comments

It’s been a great start to the summer of 2016! Two clients launched new products and another was acquired by Twitter for $150 million. We’re proud to work with this great group of entrepreneurs in IoT, insurance tech and machine learning. In the acquisition department, Magic Pony Technology, a stealth European tech company was acquired by Twitter in June. Magic Pony’s technology uses neural networks to improve images. According to a TechCrunch article the acquisition will bolster Twitter’s strategy to build it’s machine learning muscle and potentially improve how it delivers photos and videos across its apps. “Machine learning is increasingly at the…

Read More

In The News: James Shaw Talks to Drugs & Dealers Magazine

By | Brand, Entrepreneurs, Investor and VC News, Partner Insight

For the last 15 or 16 years I have been spinning life science companies out of academic institutions and one of the biggest challenges I saw 15 years ago and I still see now is funding the early stage companies on spin-out — James Shaw In the May issue of Biotech & Money’s Drugs & Dealers magazine, our co-founder James Shaw talked to the magazine about the state of the fundraising market in the UK and the firm’s role as one of the leading legal advisers in this sector. Here are some great excerpts from the article: Drugs & Dealers: Perhaps you could…

Read More

Elasmogen Spins Out Of The University Of Aberdeen

By | Biotech, Client news, Investor and VC News, investors, Life Sciences

In spin out news, we advised Elasmogen on a variety of corporate and commercial matters in connection with its spin out from the University of Aberdeen. Elasmogen is a biologics drug discovery company that specialises in antibody-like proteins called soloMER. Our legal team advised and negotiated on a variety of corporate, commercial and IP agreements, including, a subscription and shareholders’ agreement, patent licence agreements, material transfer, facilities and management and secondment agreements.

Read More

The New Seed Round

By | Entrepreneurs, Investor and VC News, investors, Partner Insight

In January 2016, Tech.eu reported there was a massive uplift of seed and series A rounds across Europe.  According to the research, the biggest increases were seen at €500K or lower (pre-seed or seed) and in rounds between €1M and €5M. Tech.eu reports that compared to one year ago, deals tripled in this bracket  –  from two to 76 in 2016. At JAG Shaw Baker, this is exactly what we’ve been seeing over the past several years — a proliferation of small Seed rounds between €150K and €500K. In addition, the two other trends from our vantage point are a shift in…

Read More

Client News: M&A, IP And Partnerships

By | Client news, Entrepreneurs, Investor and VC News, investors, M&A, Startups

From an M&A deal to Condé Nast to an interesting intellectual property matter for one of the oldest cutlery companies in Europe, here’s a short round up of some of our client’s success and news: Partnerships: For the second time in 2016, our client TransferWise has joined forces with a bank. Earlier this year it was Estonia’s largest bank LHV. This time it was a German FinTech start up, Number26 backed by Peter Thiel. Number 26 is considered to be Europe’s first mobile bank. TransferWise and Number26 have teamed up to give Number26 customers in-app access to a cheap international money-transfer service. Number26’s new service…

Read More

Poised To Win: Our Clients Makes Forbes 30 Under 30 Europe List.

By | Client news, Investor and VC News, Startups

It’s nice when our clients succeed and even nicer when they make “best of” lists – especially when it’s Forbes 30 Under 30 Europe list. This new version of the original 30 Under 30 list, looked at 300 of the young leaders in 10 industry sectors in Europe. So while the trumpets are still sounding, we wanted to give them a shout. In the world of finance, our client Index Ventures’ Ophelia Brown-Finance and Berlin-based Point 9 Capital’s Nicolas Wittenborn proved their savvy and strategy could spot the start-ups with staying power. On the technology front, we saw Alex Klein, Kano; George Burgess,…

Read More

Environmental Technologies Fund Leads $18M Funding Round For Telensa

By | Client news, Investor and VC News, Startups

Environmental Technologies Fund (ETF) recently led an $18 m funding round for Telensa, a leader in Wireless Smart City solutions. Telensa provides more options for IoT.  IoT is a smart investment. According to a study in McKinsey, IoT predicts 30 billion objects will be connected by 2020.  The funds from this new investment round will support Telensa’s next stage of profitable growth based on smart city solutions that incorporate low-power wide-area wireless technology. We are proud to be working with ETF, helping them make investments in European companies that are changing the world by delivering big environmental benefits. 

Read More

Introducing UKISS For The UK Startup Market

By | Biotech, Investor and VC News

When you’re part of an ecosystem as robust as the UK start-up market, sometimes the best way to help a market continue to grow is by doing. This is why we’re proud to have co-drafted UKISS & ASA documents for 500 Startups. The docs are great resources for founder agreements, advisor agreements, IP assignment agreements and term sheets and will be posted to 500 Startups’s KISS Portal. Some of Silicon Valley ecosystem’s success is due to legal framework that’s been created. Framework documents like NVCA, Series Seed, KISS and SAFE have helped to standardize how deals get done. The UK…

Read More

A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information

INFORMATION ABOUT OUR USE OF COOKIES Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience and also allows us to improve our website. By continuing to browse the website, you are agreeing to our use of cookies. A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. We use the following cookies: • Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page. • Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB. COOKIE DURATION The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime. You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website. Contact If you have any queries regarding this cookie policy please contact us at info@jagshawbaker.com.

Close